Drug name - Zilxi

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10213512 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US8992896 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US9675700 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US8865139 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US10322186 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US10946101 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(7 years from now)

US8945516 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(7 years from now)

US10265404 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof
Oct, 2030

(7 years from now)

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Market Authorisation Date: 28 May, 2020

Treatment: Treatment of inflammatory lesions of rosacea.

Dosage: AEROSOL, FOAM;TOPICAL

More Information on Dosage
Strength Dosage Availability
EQ 1.5% BASE AEROSOL, FOAM;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in